Lakshmi Vineela Nalla (Amit Khairnar)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Breast Cancer Risk

Transforming Growth Factor

Top Venues

Diseases (Basel, Switzerland)

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Ramakrishna Kakarla, Lakshmi Vineela Nalla, Naresh Dumala, Kojja Venkateswarlu, Matte Kasi Viswanadh, Buchi N Nalluri, Guntupalli Chakravarthy, Sajusha Duguluri, Payal Singh, Sachchida Nand Rai, Ashish Kumar, Veer Singh, Santosh Kumar Singh
WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective. Diseases (Basel, Switzerland) 11 (3) (2023)
Siva Nageswara Rao Gajula, Lakshmi Vineela Nalla
Small extracellular vesicle biomarkers in breast cancer: a real-time snapshot for early diagnosis and prognosis? Bioanalysis (2023)
Vivek P Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K Singla, Avinash D Khadela, Lalitkumar K Vora, Vladimir N Uversky
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15 (4) (2023)
Siva Nageswara Rao Gajula, Lakshmi Vineela Nalla
Small extracellular vesicle biomarkers in breast cancer: a real-time snapshot for early diagnosis and prognosis? Bioanalysis 15 (7) (2023)
Vivek P Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K Singla, Avinash D Khadela, Lalitkumar K Vora, Vladimir N Uversky
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15 (4) (2023)
Vivek P Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K Singla, Avinash D Khadela, Lalitkumar K Vora, Vladimir N Uversky
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15 (4) (2023)
Lakshmi Vineela Nalla, Piyush Gondaliya, Kiran Kalia, Lakshmi Vineela Nalla
Targeting specificity protein 1 with miR-128-3p overcomes TGF-β1 mediated epithelial-mesenchymal transition in breast cancer: An in vitro study. Molecular biology reports 49 (7) (2022)